THE ASSIGNMENT (1–2 PAGES) Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your assigned disorder in children and adolescents. Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug? Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration. Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.

THE ASSIGNMENT (1–2 PAGES) Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your assigned disorder in children and adolescents. Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug? Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration. Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.

Risk Assessment: Screening for MDD would involve a risk assessment in line with guidelines from the American Academy of Child and Adolescent Psychiatry (AACAP) to look for signs of depression such as anhedonia, irritability, and a sad mood. In the event that these signs are recognized, a thorough examination for MDD will be conducted. A Child Assessment Schedule (CAS) is a reliable and valid tool for diagnosing MDD (Cuijpers et al., 2021). Risks and Benefits of the FDA-Approved Medicine: Reduced depressive symptoms and a higher rate of remission are two of fluoxetine's most notable effects (Selph & McDonagh, 2019). On the other hand, there are several potential side effects linked with this treatment that should be taken into consideration. Risks and Benefits of the Off-Label Drug: First and foremost, Fluvoxamine can alleviate the troublesome thoughts and anxiousness that often accompany OCD, which can be a contributing factor in the development of MDD. Although the medicine has numerous positive effects, it also carries a number of hazards that should be considered (Dwyer & Bloch, 2019). Clinical Practice Guidelines: Clinical recommendations for MDD care are kept up to date by the American Psychiatric Association (APA). In the acute phase, the APA advises using antidepressants or psychotherapy. With the help of fluoxetine, depressive symptoms can be lessened, and this treatment can be kept up for a long time. Yet, the two psychotherapies that have been shown to be effective are cognitive behavioral therapy and interpersonal therapy (American Psychological Association, 2019).